H. Tan

Production and characterization of human CTLA4Ig expressed in transgenic rice cell suspension cultures.

Mi Young Park, Sang-Min Lim, Moon-sik Yang, 2007, Protein expression and purification.

Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry.

B. Shin, Yohan Choi, S. Yoo, 2011, Biomedical chromatography : BMC.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects

Ji Han Kim, Howard Lee, H. Tan, 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.

Sang-Min Lim, J. Sohn, H. Cheong, 2007, Journal of microbiology and biotechnology.

Production and characterization of long-acting recombinant human albumin-EPO fusion protein expressed in CHO cell.

J. Shin, Sang-Min Lim, Song-Jae Lee, 2009, Protein expression and purification.

Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist.

Kyung-Tae Lee, Je Hak Kim, H. Rim, 2013, Biological & pharmaceutical bulletin.

Single dose pharmacokinetics (PK) and pharmacodynamics (PD) of BR‐A‐657, an angiotensin II (AII) antagonist

S. Bryson, H. Tan, Y. Chi, 2005 .

Multiple dose pharmacokinetics (PK) and pharmacodynamics (PD) of BR‐A‐657, an angiotensin II (AII) antagonist

S. Bryson, H. Tan, Y. Chi, 2005 .